Ticker Details
Structure Therapeutics Inc.
IPO Date:	February 3, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.7B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.17 | 3.23%
Avg Daily Range (30 D):	$2.11 | 2.74%
Avg Daily Range (90 D):	$1.84 | 3.43%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	1.01M
Avg Daily Volume (90 D):	1.24M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	2,126
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$3.14M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.87M
Avg Closing Trade (30 D):	$5.31M
Avg Closing Trade (90 D):	$4.72M
Avg Closing Volume:	47.02K

News

Jan 23, 2026 @ 2:18 PM Weight Loss Drugs Market Is Crowded But Structure ... Source: Vandana Singh

Jan 13, 2026 @ 7:33 PM A 10% Owner Of Structure Therapeutics Shed Shares Source: Adé Hennis

Dec 10, 2025 @ 4:15 AM Structure Therapeutics Announces Pricing of Upsize... Source: Structure Therapeutics Inc.

Dec 7, 2025 @ 11:20 PM Structure Therapeutics to Report Data from ACCESS ... Source: Structure Therapeutics Inc.

Sep 12, 2025 @ 12:15 PM This Under-the-Radar Healthcare Stock Could Soar i... Source: Prosper Junior Bakiny

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.22	$-.37	$-.36
Diluted EPS	$-1.22	$-.37	$-.36
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-210.69M	$-65.71M	$-61.66M
Operating Income / Loss	$-247.61M	$-73.79M	$-70.45M
Cost of Revenue
Net Cash Flow	$-69.22M	$-44.11M	$-5.1M
PE Ratio